Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Biomarkers market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Biomarkers are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Biomarkers market segmented into
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Others

Based on the end-use, the global Biomarkers market classified into
Diagnostics
Drug Discovery
Personalized Medicine
Others

Based on geography, the global Biomarkers market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOMARKERS INDUSTRY
2.1 Summary about Biomarkers Industry
2.2 Biomarkers Market Trends
2.2.1 Biomarkers Production & Consumption Trends
2.2.2 Biomarkers Demand Structure Trends
2.3 Biomarkers Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Sepsis Biomarkers
4.2.2 Antibiotic Resistance Biomarkers
4.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
4.2.4 Stroke Testing Biomarkers
4.2.5 Antibiotic Stewardship Biomarkers
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Diagnostics
4.3.2 Drug Discovery
4.3.3 Personalized Medicine
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Sepsis Biomarkers
5.2.2 Antibiotic Resistance Biomarkers
5.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
5.2.4 Stroke Testing Biomarkers
5.2.5 Antibiotic Stewardship Biomarkers
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Diagnostics
5.3.2 Drug Discovery
5.3.3 Personalized Medicine
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Sepsis Biomarkers
6.2.2 Antibiotic Resistance Biomarkers
6.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
6.2.4 Stroke Testing Biomarkers
6.2.5 Antibiotic Stewardship Biomarkers
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Diagnostics
6.3.2 Drug Discovery
6.3.3 Personalized Medicine
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Sepsis Biomarkers
7.2.2 Antibiotic Resistance Biomarkers
7.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
7.2.4 Stroke Testing Biomarkers
7.2.5 Antibiotic Stewardship Biomarkers
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Diagnostics
7.3.2 Drug Discovery
7.3.3 Personalized Medicine
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Sepsis Biomarkers
8.2.2 Antibiotic Resistance Biomarkers
8.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
8.2.4 Stroke Testing Biomarkers
8.2.5 Antibiotic Stewardship Biomarkers
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Diagnostics
8.3.2 Drug Discovery
8.3.3 Personalized Medicine
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Sepsis Biomarkers
9.2.2 Antibiotic Resistance Biomarkers
9.2.3 Traumatic Brain Injury (TBI) Testing Biomarkers
9.2.4 Stroke Testing Biomarkers
9.2.5 Antibiotic Stewardship Biomarkers
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Diagnostics
9.3.2 Drug Discovery
9.3.3 Personalized Medicine
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Thermo Fisher Scientific
10.1.2 Merck
10.1.3 Bio-Rad Laboratories
10.1.4 QIAGEN
10.1.5 Roche
10.1.6 Danaher Corporation
10.1.7 Siemens Healthcare
10.1.8 Abbott
10.1.9 Agilent Technologies
10.2 Biomarkers Sales Date of Major Players (2017-2020e)
10.2.1 Thermo Fisher Scientific
10.2.2 Merck
10.2.3 Bio-Rad Laboratories
10.2.4 QIAGEN
10.2.5 Roche
10.2.6 Danaher Corporation
10.2.7 Siemens Healthcare
10.2.8 Abbott
10.2.9 Agilent Technologies
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Biomarkers Product Type Overview
2.Table Biomarkers Product Type Market Share List
3.Table Biomarkers Product Type of Major Players
4.Table Brief Introduction of Thermo Fisher Scientific
5.Table Brief Introduction of Merck
6.Table Brief Introduction of Bio-Rad Laboratories
7.Table Brief Introduction of QIAGEN
8.Table Brief Introduction of Roche
9.Table Brief Introduction of Danaher Corporation
10.Table Brief Introduction of Siemens Healthcare
11.Table Brief Introduction of Abbott
12.Table Brief Introduction of Agilent Technologies
13.Table Products & Services of Thermo Fisher Scientific
14.Table Products & Services of Merck
15.Table Products & Services of Bio-Rad Laboratories
16.Table Products & Services of QIAGEN
17.Table Products & Services of Roche
18.Table Products & Services of Danaher Corporation
19.Table Products & Services of Siemens Healthcare
20.Table Products & Services of Abbott
21.Table Products & Services of Agilent Technologies
22.Table Market Distribution of Major Players
23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
25.Table Global Biomarkers Market Forecast (Million USD) by Region 2021f-2026f
26.Table Global Biomarkers Market Forecast (Million USD) Share by Region 2021f-2026f
27.Table Global Biomarkers Market Forecast (Million USD) by Demand 2021f-2026f
28.Table Global Biomarkers Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Biomarkers Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Biomarkers Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Biomarkers Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Biomarkers Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Biomarkers Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Biomarkers Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Biomarkers Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Sepsis Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Antibiotic Resistance Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Traumatic Brain Injury (TBI) Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Stroke Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Antibiotic Stewardship Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Sepsis Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Antibiotic Resistance Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Traumatic Brain Injury (TBI) Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Stroke Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Antibiotic Stewardship Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Sepsis Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Antibiotic Resistance Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Traumatic Brain Injury (TBI) Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Stroke Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Antibiotic Stewardship Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Sepsis Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Antibiotic Resistance Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Traumatic Brain Injury (TBI) Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Stroke Testing Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Antibiotic Stewardship Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Sepsis Biomarkers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Antibiotic Resista

2023-2028 Global and Regional Genomic Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Genomic Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this f...

2023-2028 Global and Regional Antibiotic Stewardship Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Antibiotic Stewardship Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...

2023-2028 Global and Regional Medical Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Medical Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this f...

2023-2028 Global and Regional Central Nervous System Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Central Nervous System Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pl...

2023-2028 Global and Regional Sepsis Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Sepsis Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fi...

2023-2028 Global and Regional Genomics Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Genomics Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...

2023-2028 Global and Regional Commercializing Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Commercializing Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Serum Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Serum Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...

2023-2028 Global and Regional Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry Status and Prospects Professional Market Research Report Standard Version...

The global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID...

2023-2028 Global and Regional Serum Cancer Biomarkers Industry Status and Prospects Professional Market Research Report Standard Version...

The global Serum Cancer Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...